An article from the publishers of Science on 22 March on WHO megatrials. WHO is focusing on what it says are the four most promising therapies: an experimental antiviral compound called remdesivir; the malaria medications chloroquine and hydroxychloroquine; a combination of two HIV drugs, lopinavir, and ritonavir; and that same combination plus interferon-beta, an immune system messenger that can help cripple viruses.
You may also like
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe
October 20, 2020
Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest–posttest comparison group study
August 17, 2020
It is Time to Address Airborne Transmission of COVID-19
July 13, 2020